The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 2SEVENTY BIO INC | COMMON STOCK | 901384107 | BBG00YV1J631 | 31,852,964 | 5,953,825 | SH | SOLE | 5,953,825 | 0 | 0 | ||
| ACELYRIN INC | COM | 00445A100 | BBG00YJKJ8J2 | 2,675,558 | 396,379 | SH | SOLE | 396,379 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | BBG001SD42R0 | 10,710,050 | 12,022,957 | SH | SOLE | 12,022,957 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | BBG001S7K151 | 33,159,654 | 6,527,491 | SH | SOLE | 6,527,491 | 0 | 0 | ||
| BURNING ROCK BIOTECH LTD | SPONSORED ADS | 12233L107 | BBG00V1JWFQ1 | 7,019,549 | 9,640,914 | SH | SOLE | 9,640,914 | 0 | 0 | ||
| CARIBOU BIOSCIENCES INC | COM | 142038108 | BBG008G28LH7 | 5,492,229 | 1,068,527 | SH | SOLE | 1,068,527 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | BBG001S7QN20 | 121,713,000 | 2,900,000 | SH | SOLE | 2,900,000 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | BBG007DHY102 | 57,120,000 | 8,500,000 | SH | SOLE | 8,500,000 | 0 | 0 | ||
| CORCEPT THERAPEUTICS INC | COM | 218352102 | BBG001S8QGV1 | 14,758,821 | 585,900 | SH | Put | SOLE | 585,900 | 0 | 0 | |
| DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | BBG001S7HTB7 | 52,615,670 | 4,239,780 | SH | SOLE | 4,239,780 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | BBG001SNZLM7 | 14,153,750 | 1,625,000 | SH | SOLE | 1,625,000 | 0 | 0 | ||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | BBG001V0GFD7 | 33,162,779 | 2,248,324 | SH | SOLE | 2,248,324 | 0 | 0 | ||
| NATERA INC | COM | 632307104 | BBG001V0FSF8 | 182,920,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | BBG002B63KP4 | 33,102,921 | 1,144,242 | SH | SOLE | 1,144,242 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | BBG001T94MP6 | 11,309,758 | 2,001,727 | SH | SOLE | 2,001,727 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG001T92272 | 134,708,000 | 5,660,000 | SH | SOLE | 5,660,000 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | BBG001SL72C5 | 15,420,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| TYRA BIOSCIENCES INC | COM | 90240B106 | BBG00RCQD9F9 | 8,449,116 | 515,190 | SH | SOLE | 515,190 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | BBG009PHHPP4 | 50,890,950 | 745,000 | SH | SOLE | 745,000 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | BBG00Q72WYH2 | 65,835,055 | 1,526,787 | SH | SOLE | 1,526,787 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | BBG001S68LJ8 | 41,801,000 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | BBG002H24301 | 2,344,186 | 133,877 | SH | SOLE | 133,877 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | BBG00B642V63 | 24,260,946 | 3,932,082 | SH | SOLE | 3,932,082 | 0 | 0 | ||